In a previous work by our group, we investigated the prognostic role of additional biomarkers (ARID1A and CTNNB1) in endometrial carcinoma in a subset of the analyzed cohort showing the relevance of an improved surrogate molecular classification (10). The gene discussed is ARID1A; the disease is endometrial carcinoma.